Chemical Biology and Therapeutics, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
Cardiovascular and Metabolic Disease Area, Novartis Institutes for Biomedical Research, Cambridge, MA 02139.
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10360-10365. doi: 10.1073/pnas.1820171116. Epub 2019 May 9.
Lipoprotein lipase (LPL) plays a central role in triglyceride (TG) metabolism. By catalyzing the hydrolysis of TGs present in TG-rich lipoproteins (TRLs), LPL facilitates TG utilization and regulates circulating TG and TRL concentrations. Until very recently, structural information for LPL was limited to homology models, presumably due to the propensity of LPL to unfold and aggregate. By coexpressing LPL with a soluble variant of its accessory protein glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 (GPIHBP1) and with its chaperone protein lipase maturation factor 1 (LMF1), we obtained a stable and homogenous LPL/GPIHBP1 complex that was suitable for structure determination. We report here X-ray crystal structures of human LPL in complex with human GPIHBP1 at 2.5-3.0 Å resolution, including a structure with a novel inhibitor bound to LPL. Binding of the inhibitor resulted in ordering of the LPL lid and lipid-binding regions and thus enabled determination of the first crystal structure of LPL that includes these important regions of the protein. It was assumed for many years that LPL was only active as a homodimer. The structures and additional biochemical data reported here are consistent with a new report that LPL, in complex with GPIHBP1, can be active as a monomeric 1:1 complex. The crystal structures illuminate the structural basis for LPL-mediated TRL lipolysis as well as LPL stabilization and transport by GPIHBP1.
脂蛋白脂肪酶 (LPL) 在甘油三酯 (TG) 代谢中发挥核心作用。通过催化富含甘油三酯的脂蛋白 (TRLs) 中 TG 的水解,LPL 促进 TG 的利用,并调节循环 TG 和 TRL 浓度。直到最近,LPL 的结构信息还仅限于同源模型,这可能是由于 LPL 倾向于展开和聚集。通过与可溶性辅助蛋白糖基磷脂酰肌醇锚定高密度脂蛋白结合蛋白 1 (GPIHBP1) 的变体以及其伴侣蛋白脂肪酶成熟因子 1 (LMF1) 共同表达 LPL,我们获得了一种稳定且均一的 LPL/GPIHBP1 复合物,适合进行结构测定。我们在此报告了人 LPL 与 GPIHBP1 复合物的 X 射线晶体结构,分辨率为 2.5-3.0 Å,其中包括一个与新型抑制剂结合的 LPL 的结构。抑制剂的结合导致 LPL 盖和脂质结合区域的有序化,从而能够确定包含该蛋白这些重要区域的第一个 LPL 晶体结构。多年来,人们一直认为 LPL 仅作为同源二聚体发挥作用。这里报告的结构和额外的生化数据与一项新报告一致,即与 GPIHBP1 结合的 LPL 可以作为单体 1:1 复合物发挥活性。晶体结构阐明了 LPL 介导的 TRL 脂肪分解以及 GPIHBP1 对 LPL 的稳定和转运的结构基础。